InvestorsHub Logo
Replies to #22737 on FDA Plays
icon url

io_io

09/19/11 1:04 PM

#22763 RE: DewDiligence #22737

Dew: Are there any biotechs that recently turned profitable?
-------------------------------------------------------------------------
Here’s one: #msg-66992042.



MNTA's profitability didn't last long:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=67206795
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=67217652

Why? Fact is that MNTA is more a Generics than a Biotech company. Those Generics companies dont have an "NME" (new molecular entity) status nor patent protection for their drugs.
icon url

io_io

10/24/11 9:55 PM

#22874 RE: DewDiligence #22737

Are there any biotechs that recently turned profitable?
-------------------------------------------------------------------------------- Here’s one: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=66992042


Well Dew it definitely wasn't one, because your MNTA is going to turn even more un-profitable with this news: http://finance.yahoo.com/news/Momenta-Pharmaceuticals-pz-2375555192.html?x=0&.v=1

Also I do not expect FDA approval for m-Cop anytime soon.